PETS: PetMed Express, Inc. Stock

by  •  • Comments Off on PETS: PetMed Express, Inc. Stock

SIC 5912 – Drug Stores and Proprietary Stores

Valuation
Market Cap ($M) 84.64
Enterprise Value ($M) 35.21
Book Value ($M) 100.06
Book Value / Share 4.91
Price / Book 0.85
NCAV ($M) 22.26
NCAV / Share 1.09
Price / NCAV 3.80

Profitability (mra)
Return on Invested Capital (ROIC) -0.03
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio 0.84
Current Ratio 1.32

Balance Sheet (mrq) ($M)
Current Assets 95.55
Assets 173.35
Liabilities 73.29
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G Renaissance Technologies Llc 6.36 64.64
02-13 13G/A Vanguard Group Inc 5.57 -20.63
01-25 13G/A BlackRock Inc. 8.40 5.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-15 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-04-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 o T
2024-04-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 o TRANSITION REPORT
2024-04-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 202
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 o TRANSITION REPOR
2023-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 o TRANSITION REPORT PUR
2023-05-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 41,822 102,919 40.64
2024-04-23 46,087 95,431 48.29
2024-04-22 83,652 127,153 65.79
2024-04-19 54,272 127,949 42.42

(click for more detail)

Similar Companies
WBA – Walgreens Boots Alliance, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Petmed Express